What You Need to Know About the Expanding EU Investigation into Ozempic- National
Descrease article font size Increase article font size The European Medicines Agency (EMA) said on Tuesday it has extended its probe into Novo Nordisk’s NOVOb.CO diabetes drugs Ozempic and weight-loss treatment Saxenda, …